FLUVAC INNOVATOR^® EHV-4/1

Product Highlights

• FLUVAC INNOVATOR is the only vaccine with EIV strain KY ’97 that has demonstrated protection against heterologous challenge with EIV strain OH ’03²
• FLUVAC INNOVATOR is the only EIV vaccine shown to help protect against clinical signs for seven months against a heterologous, dual-strain challenge³
• In addition to EIV, FLUVAC INNOVATOR vaccines also contain both EHV-1 and EHV-4 to help protect against rhinopneumonitis
• Only INNOVATOR vaccines are adjuvanted with MetaStim for improved immune response⁴

FLUVAC INNOVATOR

Inject 1 mL dose intramuscularly using aseptic technique.

Administer a second 1 mL dose 3 to 4 weeks after the first dose in unvaccinated or naïve horses.

A 1 mL annual revaccination in previously vaccinated horses is recommended.

Always read and follow label indications

Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make exposure likely.

References:

1. Doane Market Research Inc. and CEESA International Sales Survey (CISS), September 2009
2. Data on file, Study Report No. B671-08-004.R, Zoetis Inc.
3. “Data on file, Study Report No. B671-02-001.P, Zoetis Inc.”
4. Davis EG, et al. Investigation of Antigen Specific Lymphocyte Responses in Healthy Horses Vaccinated with an Inactivated West Nile Virus Vaccine. Vet Immunol Immunopathol 2008;126:293–301